OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 64 filers reported holding OPHTHOTECH CORP in Q4 2013. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $4,000 | -84.6% | 3,372 | -69.8% | 0.00% | – |
Q3 2018 | $26,000 | -7.1% | 11,162 | +8.8% | 0.00% | – |
Q2 2018 | $28,000 | -80.3% | 10,262 | -73.6% | 0.00% | -100.0% |
Q1 2017 | $142,000 | -83.7% | 38,857 | -78.5% | 0.00% | -75.0% |
Q4 2016 | $871,000 | -20.4% | 180,409 | +660.4% | 0.01% | -33.3% |
Q3 2016 | $1,094,000 | -11.9% | 23,725 | -2.5% | 0.01% | -20.0% |
Q2 2016 | $1,242,000 | +1472.2% | 24,332 | +1206.8% | 0.02% | +1400.0% |
Q1 2016 | $79,000 | -67.1% | 1,862 | -39.2% | 0.00% | -66.7% |
Q4 2015 | $240,000 | +24.4% | 3,062 | -35.8% | 0.00% | 0.0% |
Q3 2015 | $193,000 | -71.1% | 4,766 | -62.8% | 0.00% | -66.7% |
Q2 2015 | $667,000 | -0.3% | 12,817 | -10.9% | 0.01% | -18.2% |
Q1 2015 | $669,000 | +146.0% | 14,388 | +137.8% | 0.01% | +175.0% |
Q4 2014 | $272,000 | +53.7% | 6,051 | +33.0% | 0.00% | +33.3% |
Q3 2014 | $177,000 | -39.4% | 4,551 | -34.0% | 0.00% | -25.0% |
Q2 2014 | $292,000 | -16.1% | 6,900 | -29.0% | 0.00% | -33.3% |
Q1 2014 | $348,000 | +20.0% | 9,723 | +8.6% | 0.01% | +50.0% |
Q4 2013 | $290,000 | – | 8,951 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SV Health Investors, LLC | 2,053,143 | $95,533,000 | 31.57% |
Clarus Ventures, LLC | 1,554,744 | $72,342,000 | 30.07% |
Novo Holdings A/S | 4,910,487 | $228,485,000 | 19.43% |
JHL Capital Group LLC | 3,265,000 | $151,920,000 | 13.98% |
AlpInvest Partners B.V. | 37,500 | $1,745,000 | 3.26% |
Opaleye Management Inc. | 105,000 | $4,886,000 | 2.27% |
IMA Wealth, Inc. | 67,930 | $3,161,000 | 1.54% |
Hillview Capital Advisors, LLC | 34,830 | $1,621,000 | 1.40% |
Cheyne Capital Management (UK) LLP | 124,151 | $5,777,000 | 1.39% |
WILLIAM HARRIS INVESTORS INC | 106,158 | $4,939,000 | 1.30% |